Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India
AK Singh, R Singh, SR Joshi, A Misra - Diabetes & Metabolic Syndrome …, 2021 - Elsevier
Background and aims There are increasing case reports of rhino-orbital mucormycosis in
people with coronavirus disease 2019 (COVID-19), especially from India. Diabetes mellitus …
people with coronavirus disease 2019 (COVID-19), especially from India. Diabetes mellitus …
The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries
M Hoenigl, D Seidel, A Carvalho… - The Lancet …, 2022 - thelancet.com
Reports of COVID-19-associated mucormycosis have been increasing in frequency since
early 2021, particularly among patients with uncontrolled diabetes. Patients with diabetes …
early 2021, particularly among patients with uncontrolled diabetes. Patients with diabetes …
COVID‐19‐associated mucormycosis: an updated systematic review of literature
In its wake, the COVID‐19 pandemic has ushered in a surge in the number of cases of
mucormycosis. Most cases are temporally linked to COVID‐19; hence, the entity is described …
mucormycosis. Most cases are temporally linked to COVID‐19; hence, the entity is described …
Epidemiology and pathophysiology of COVID-19-associated mucormycosis: India versus the rest of the world
Abstract The coronavirus disease 2019 (COVID-19) pandemic has led to a concerning
resurgence of mucormycosis. More than 47,000 cases of mucormycosis were reported in …
resurgence of mucormycosis. More than 47,000 cases of mucormycosis were reported in …
COVID-19 and mucormycosis superinfection: the perfect storm
JA Al-Tawfiq, S Alhumaid, AN Alshukairi, MH Temsah… - Infection, 2021 - Springer
Background The recent emergence of the Coronavirus Disease (COVID-19) disease had
been associated with reports of fungal infections such as aspergillosis and mucormycosis …
been associated with reports of fungal infections such as aspergillosis and mucormycosis …
Mucormycosis and COVID‐19: an epidemic within a pandemic in India
Abstract Importance Coronavirus disease (COVID‐19) causes an immunosuppressed state
and increases risk of secondary infections like mucormycosis. We evaluated clinical …
and increases risk of secondary infections like mucormycosis. We evaluated clinical …
Mucormycosis in patients with COVID‐19: a cross‐sectional descriptive multicentre study from Iran
Purpose The aim of the study was to report clinical features, contributing factors and
outcome of patients with coronavirus disease 2019 (COVID‐19)‐associated mucormycosis …
outcome of patients with coronavirus disease 2019 (COVID‐19)‐associated mucormycosis …
[HTML][HTML] High mortality co-infections of COVID-19 patients: mucormycosis and other fungal infections
Severe COVID-19 disease is associated with an increase in pro-inflammatory markers, such
as IL-1, IL-6, and tumor necrosis alpha, less CD4 interferon-gamma expression, and fewer …
as IL-1, IL-6, and tumor necrosis alpha, less CD4 interferon-gamma expression, and fewer …
COVID-19-associated mucormycosis: Case report and systematic review
Background Increasing number of patients with COVID-19-associated mucormycosis have
been reported, especially from India recently. We have described a patient with COVID-19 …
been reported, especially from India recently. We have described a patient with COVID-19 …
Invasive fungal infections complicating COVID-19: a narrative review
G Casalini, A Giacomelli, A Ridolfo, C Gervasoni… - Journal of Fungi, 2021 - mdpi.com
Invasive fungal infections (IFIs) can complicate the clinical course of COVID-19 and are
associated with a significant increase in mortality, especially in critically ill patients admitted …
associated with a significant increase in mortality, especially in critically ill patients admitted …